Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Total 13F shares
-
71,399,076
-
Share change
-
-1,203,556
-
Total reported value
-
$26,844,190,218
-
Put/Call ratio
-
95%
-
Price per share
-
$375.96
-
Number of holders
-
627
-
Value change
-
-$489,810,414
-
Number of buys
-
291
-
Number of sells
-
271
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2017
As of 31 Dec 2017 REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) had 627 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 71,399,076 shares of stock of the company.
Largest 10 holders included BlackRock Inc., FMR LLC, Vanguard Group Inc, Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, LOOMIS SAYLES & CO L P, JANUS HENDERSON GROUP PLC, and POLEN CAPITAL MANAGEMENT LLC.
This table shows 628 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.